UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
November 4, 2009 (November 4, 2009)
____________
DIALYSIS CORPORATION OF AMERICA
(Exact name of registrant as specified in its charter)
Florida 0-8527 59-1757642
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1302 Concourse Drive, Suite 204, Linthicum, MD 21090
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (410) 694-0500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On November 4, 2009, Dialysis Corporation of America issued a press
release announcing its financial results for the third quarter ended
September 30, 2009. A copy of the November 4, 2009 press release is attached
as an exhibit to this Current Report and is incorporated herein by reference.
The information furnished pursuant to Item 2.02, including the Exhibit
(99)(i), shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933.
Dialysis Corporation of America will be hosting a conference call in
conjunction with the press release of its financial results attached as the
exhibit to this current report. The conference call will be held on
Thursday, November 5, 2009 at 10:00 a.m. EST. The call is accessible either
by dialing 1-866-814-8476 (and providing attendee code 1405582), or by
simulcast on the internet at http://www.startconference.com using Conference
ID number 2135668. Participants may be asked to provide the title of the
conference call, which is "Dialysis Corporation of America Third Quarter
Earnings." A copy of this current report on Form 8-K and the attached press
release announcing the financial results for the third quarter ended
September 30, 2009 will be available through the company's website,
www.dialysiscorporation.com, under the "Investor Relations - SEC Filings"
tabs. A replay of the conference call will be available on the company's
website for a period of thirty days following the conference call.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
(99) Additional exhibits
(i) Press Release dated November 4, 2009.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DIALYSIS CORPORATION OF AMERICA
/s/ Stephen W. Everett
By______________________________
STEPHEN W. EVERETT
President and Chief Executive Officer
Dated: November 4, 2009
EXHIBIT INDEX
Exhibit
Number
-------
(99)(i) Press Release dated November 4, 2009.